Starting on:
Apr 24, 2020
Ending on:
Aug 5, 2020
Moderator(s):
Venue:
Max Credits:
3 Points
Provider:
Kenya Society of Hematology & Oncology
Claim Points
Apr 24, 2020
Ending on:
Aug 5, 2020
Moderator(s):
Max Credits:
3 Points
Provider:
Kenya Society of Hematology & Oncology
Claim Points
Clinical considerations in treatment sequencing for mCRC
Starting on:
Apr 24, 2020 8:00 AM
Apr 24, 2020 8:00 AM
Ending on:
Aug 5, 2020 8:00 AM
Aug 5, 2020 8:00 AM
Venue:
Description
WHAT DO YOU NEED TO THINK ABOUT WHEN SELECTING CHEMOTHERAPY AND BIOLOGIC COMBINATIONS IN THE TREATMENT OF PATIENTS WITH MCRC
Objectives
Formulate treatment strategies based on a patientâ??s tumor characteristics, including the role of repeat genetic testing, therapy rechallenge, and combination therapy to improve outcomes and survival.
Evaluate approaches to assess mechanisms of treatment resistance, and the role of monitoring for resistance to assist in optimizing clinical decision-making.
Presenters
-
Prof.
Alfredo L. Falcone
Global Oncology Academy Faculty
Global Oncology Academy Faculty -
Prof.
Sebastian Stintzing
Global Oncology Academy Faculty
Global Oncology Academy Faculty -
Prof.
Tianshu Liu
Global Oncology Academy Faculty
Global Oncology Academy Faculty